Just a short while after securing a CE Mark for its second generation device, Abbott has been granted FDA clearance for FreeStyle LibreLink, a companion mobile app for its 10 to 14-day CGM. The launch ...
Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...
The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, including MRI under certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback